The COVID-19 pandemic demands assimilation of all biomedical knowledge to decode
mechanisms of pathogenesis. Despite the recent renaissance in neural networks, a platform for …

Rare monogenic disorders often share molecular etiologies involved in the pathogenesis of
common diseases. Congenital disorders of glycosylation (CDG) and deglycosylation (CDDG…

Decoding disease mechanisms for addressing unmet clinical need demands the rapid
assimilation of the exponentially growing biomedical knowledge. These are either inherently …

Background and Aims Nonalcoholic Fatty Liver Disease (NAFLD) is the most common
global cause of chronic liver disease. Therapeutic interventions are rapidly advancing for its …

Congenital disorders of glycosylation (CDG) and deglycosylation (CDDG) are a collection of
rare pediatric disorders with symptoms that range from mild to life threatening. They typically …

Intensive care unit (ICU) admissions and mortality in severe COVID-19 patients are driven
by “cytokine storms” and acute respiratory distress syndrome (ARDS). Interim clinical trial …

Lifestyle modification is the foundation of treatment recommendations for non-alcoholic fatty
liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The design of clinical trials …

The growing prevalence of AI in industry and the dominance of a handful of model classes
have contributed to a community-wide shift toward more data-centric AI. As an AI-driven …